Search
Work Product Protection for Patient Safety Information Charles Kelly, MS, partner, at Saul Ewing LLP, will walk attendees through two important pieces of legislation that protect healthcare workers: the Patient Safety and Quality Improvement Act of 2005, which ensures federal privilege and...
On December 2, 2022, the Office for Civil Rights (“ OCR”) and the Substance Abuse and Mental Health Services Administration (“ SAMHSA”) within the U.S. Department of Health and Human Services (“ HHS”) issued a Notice of Proposed Rulemaking (“ NPRM”) to revise the Confidentiality of Substance Use...
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
In this engaging and useful session, Mr. Havens will use facts from recent food and beverage cases and recent instances of enforcement to provide practical takeaways to help the industry comply with applicable requirements and take defensible positions when developing food labels and product claims.
MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...
The Lawsuits and Law Firms Behind the Gaming Industry Another source of litigation for the games indsutry are so-called “loot boxes,” or purchasable opportunities to receive in-game items, with more powerful or valuable items being rarer. Loot boxes have been likened to gambling by regulators and...
Allison Burdette, associate at Saul Ewing, will be presenting to the Children's Hospital of Los Angeles on October 12, 2022. She will focus on the topics of insight into regulatory/insurance litigations around compliance matters (i.e., Anti-kickback, Physician Self-Referrals, HIPAA, False Claims...
Washington, D.C.’s (D.C. or the District) Alcoholic Beverage Regulation Administration (ABRA) is now accepting applications for three new alcohol licenses that were created by the Reopen Washington D.C. Alcoholic Beverage Regulation Administration Amendment Act of 2022. We detail each of these...
The U.S. Food and Drug Administration (FDA or the Agency) today published in the Federal Register a proposed rule that, if finalized, would update the standards that food products must meet in order to be labeled as “healthy.” Per FDA, the proposed rule would “align the definition of ‘healthy’ with...
Attorney and host of the “Lawyers With Game” video podcast, Darius Gambino discuses The Ohio State University's trademark of the word "The" with NBC Legal Analyst Danny Cevallos on the Michael Smerconish Program, Tuesday 28 June 2022.
Angela de Cespedes of Saul Ewing was appointed vice chair of the ABA Forum on the Entertainment and Sports’ Industries’ Litigation Division.